Novavax (NVAX) Lags on Q2 Earnings & Sales, Cuts '24 Outlook
Novavax(NVAX) ZACKS·2024-08-10 00:10
Novavax (NVAX) posted earnings per share of 99 cents in second-quarter 2024, missing the Zacks Consensus Estimate of 415.5 million, also missing the Zacks Consensus Estimate of 19.9 million in product sales compared with $285.2 million in the year-ago quarter. While this reported figure did bea ...